Expression analysis of genes at 3q26-q27 involved in frequent amplification in squamous cell lung carcinoma.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  E. Zabarovsky,et al.  NotI linking/jumping clones of human chromosome 3: mapping of the TFRC, RAB7 and HAUSP genes to regions rearranged in leukemia and deleted in solid tumors , 1997, FEBS letters.

[3]  E. Meese,et al.  Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. , 1997, Cancer research.

[4]  E. Meese,et al.  DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. , 1996, European journal of cancer.

[5]  J. Battey,et al.  Insulin-like Growth Factor Expression in Human Cancer Cell Lines (*) , 1996, The Journal of Biological Chemistry.

[6]  K. Leslie,et al.  Transferrin receptor expression in nonsmall cell lung cancer. Histopathologic and clinical correlates , 1995, Cancer.

[7]  J. Shutter,et al.  Cloning and Characterization of the Human Megakaryocyte Growth and Development Factor (MGDF) Gene (*) , 1995, The Journal of Biological Chemistry.

[8]  A. Hagemeijer,et al.  AMLI fusion transcripts in t(3;21) positive leukemia: Evidence of molecular heterogeneity and usage of splicing sites frequently involved in the generation of normal AMLI transcripts , 1994, Genes, chromosomes & cancer.

[9]  J. Steitz,et al.  The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  I. Petersen,et al.  Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. , 1994, Cancer research.

[11]  H. Minn,et al.  Expression of glucose transporters in head‐and‐neck tumors , 1994, International journal of cancer.

[12]  L. B. Daniels,et al.  A sequence-tagged site map of human chromosome 11. , 1993, Genomics.

[13]  A. Traynor-Kaplan,et al.  A product of phosphatidylinositol‐3 kinase is elevated in dividing HT29 colonic epithelial cells , 1993, FEBS letters.

[14]  D. V. Von Hoff,et al.  Evidence of gene amplification in the form of double minute chromosomes is frequently observed in lung cancer. , 1993, Cancer genetics and cytogenetics.

[15]  G. Nicolson,et al.  Lung‐derived growth factor that stimulates the growth of lung‐metastasizing tumor cells: Identification as transferrin , 1991, Journal of cellular biochemistry.

[16]  W Godolphin,et al.  Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. , 1989, Science.

[17]  P. Seligman,et al.  Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation. , 1988, The Journal of clinical investigation.

[18]  J. Yokota,et al.  Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. , 1988, Oncogene.

[19]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[20]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[21]  M. Koike,et al.  Amplification and enhanced expression of cellular oncogene c-Ki-ras-2 in a human epidermoid carcinoma of the lung. , 1985, Japanese journal of cancer research : Gann.

[22]  G. Sato,et al.  Replacement of serum by hormones permits growth of cells in a defined medium , 1976, Nature.

[23]  D. Tormey,et al.  Biological effects of transferrin on human lymphocytes in vitro. , 1972, Experimental cell research.

[24]  E. Meese,et al.  Comparative PCR: an improved method to detect gene amplification. , 1998, BioTechniques.

[25]  S. Kitano,et al.  Amplification and overexpression of cyclin D1 in aggressive human esophageal cancer. , 1998, Oncology reports.

[26]  H. Soreq,et al.  Mutations and impaired expression in the ACHE and BCHE genes: neurological implications. , 1994, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[27]  C. Downes,et al.  Phosphoinositide 3-kinase: a new effector in signal transduction? , 1991, Cellular signalling.

[28]  G. Tonini,et al.  N‐myc Oncogene Amplification in a Patient with IV‐S Neuroblastoma , 1987, The American journal of pediatric hematology/oncology.

[29]  M. Schwab,et al.  Oncogene amplification in tumor cells. , 1986, Advances in cancer research.

[30]  J. Milbrandt,et al.  DNA sequence amplification in mammalian cells. , 1984, International review of cytology.